Skip to content

4Accepted Aug 12, 5:30 PM ET

Treace Medical (TMCI) Chief Legal Officer Surrenders 16,253 Shares for Taxes

TMCITREACE MEDICAL CONCEPTS, INC.

Accepted (ET)

5:30 PM

Aug 12, 2026

Filed

Aug 12, 2026

Documents

1

Size

4.8 KB

Summary

Treace Medical (TMCI) Chief Legal Officer Surrenders 16,253 Shares for Taxes

Updated

What Happened

  • Scot Michael Elder, Chief Legal & Compensation Officer and Corporate Secretary of Treace Medical Concepts, reported the disposition of 16,253 shares on 2026-08-09. The filing lists the transaction code F (payment of exercise price or tax liability) and shows a price of $0.00, indicating the shares were surrendered/withheld to cover taxes rather than sold for cash.

Key Details

  • Transaction date: 2026-08-09; SEC filing date: 2026-08-12.
  • Shares involved: 16,253 shares; reported price: $0.00; cash proceeds shown: $0.
  • Shares owned after transaction: not specified in this filing excerpt.
  • Footnote: filing notes the insider “Includes 590,697 restricted stock units,” which likely relates to outstanding unvested/vested awards.
  • Transaction type/code: F = payment of exercise price or tax liability (commonly used when shares are surrendered to satisfy tax withholding).

Context

  • This is a routine tax-withholding action rather than an open-market sale or purchase; such transactions are common when awards vest and taxes are due. It does not necessarily signal a change in the insider’s view of the company.

AI-written summary · check the filing